I just got this...Tue, 26 Oct at 9:31 amTuesday, 26 October 2021
RMD - RESMED INC
Credit Suisse rates RMD as Outperform (1) - In a preview of ResMed Inc's results due on October 29, Credit Suisse forecasts Q1 revenue growth of 17%, earnings (EBIT) to rise by 13% and Non-GAAP profit up by 11.6% versus the previous corresponding period. A dividend of US$0.42 is estimated.
The analyst thinks recent share underperformance provides significant valuation upside. The $44 target price and Outperform rating are unchanged. It's thought the market is underestimating the multi-year tailwind from the Philips recall.
Target price is $44.00 Current Price is $35.99 Difference: $8.01 If RMD meets the Credit Suisse target it will return approximately 22% (excluding dividends, fees and charges). Current consensus price target is $38.21, suggesting upside of 6.2%(ex-dividends)The company's fiscal year ends in June.
Forecast for FY22:
Credit Suisse forecasts a full year FY22 dividend of 22.56 cents and EPS of 82.83 cents . At the last closing share price the estimated dividend yield is 0.63%. At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 43.45. How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 84.0, implying annual growth of N/A. Current consensus DPS estimate is 22.8, implying a prospective dividend yield of 0.6%. Current consensus EPS estimate suggests the PER is 42.8.
Forecast for FY23:
Credit Suisse forecasts a full year FY23 dividend of 23.62 cents and EPS of 99.47 cents . At the last closing share price the estimated dividend yield is 0.66%. At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 36.18. How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 95.2, implying annual growth of 13.3%. Current consensus DPS estimate is 24.1, implying a prospective dividend yield of 0.7%. Current consensus EPS estimate suggests the PER is 37.8.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.Market Sentiment: 0.3All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
- Forums
- ASX - By Stock
- Tuesday, 26 October 2021
RMD
resmed inc
Add to My Watchlist
0.17%
!
$42.27

I just got this...Tue, 26 Oct at 9:31 amTuesday, 26 October...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$42.27 |
Change
0.070(0.17%) |
Mkt cap ! $24.48B |
Open | High | Low | Value | Volume |
$42.44 | $42.59 | $42.19 | $23.38M | 553.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 536 | $42.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$42.37 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 536 | 42.200 |
1 | 118 | 42.190 |
1 | 100 | 42.110 |
1 | 800 | 42.100 |
1 | 238 | 42.010 |
Price($) | Vol. | No. |
---|---|---|
42.400 | 500 | 1 |
42.410 | 536 | 2 |
42.600 | 349 | 2 |
42.680 | 100 | 1 |
42.750 | 40 | 1 |
Last trade - 16.14pm 10/09/2025 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
EVR
EV RESOURCES LTD
Shane Menere, Non-Executive Chairman
Shane Menere
Non-Executive Chairman
SPONSORED BY The Market Online